CAR-T in the Courts – Genetic Engineering & Biotechnology News
|
CAR–T in the Courts
Genetic Engineering & Biotechnology News A patent fight continues over engineered chimeric antigen receptors for T–cell therapies (CAR-T). In December 2016, the Patent Trial and Appeal Board upheld a patent for a specific design of a chimeric antigen receptor (CAR) designed by researchers at … |
